Navigation Links
Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis
Date:5/4/2009

PARIS, May 4 /PRNewswire/ -- Fovea Pharmaceuticals announced today positive results from its clinical proof-of-concept trial to assess the therapeutic effect of Prednisporin(TM) (FOV1101) in patients with persistent allergic conjunctivitis.

Prednisporin(TM) had the same efficacy and a better safety profile (no increase in intra-ocular pressure) than PredForte(TM), a prescription drug with a 10 fold higher dose of prednisolone acetate, in patients treated for the signs and symptoms (itching and redness) of persistent ocular allergic inflammation. A one-week pre-treatment with Pataday(TM) (an anti-histamine) had negligible effect on these parameters in this patient population.

The prospective, multicenter, randomized, double masked, bilateral comparison study with 150 patients was conducted by Ora Inc., in the USA utilizing Ora's Enviro-CAC(TM) clinical technology. The combination therapy of low doses cyclosporine A and prednisolone acetate was compared to PredForte(TM) alone or vehicle alone during a 2-week dosing period.

"We are extremely pleased with these results, and they are totally in line with our expectations," said Bernard Gilly, Chairman and Chief Executive Officer of Fovea. "We believe that Prednisporin(TM) has the potential to provide safe and effective therapy to millions of patients suffering from chronic inflammatory conjunctivitis, a complex indication, that is not addressed by existing treatments."

Prednisporin(TM) is the first combination therapy developed for the treatment of persistent allergic conjunctivitis. It is a proprietary topical formulation of lower than the usual therapeutic doses prednisolone acetate and cyclosporine A, to retain the efficacy of a very potent steroid with an improved safety profile. The concept was first discovered and patented by CombinatoRx (Nasdaq: CRXX
'/>"/>

SOURCE Fovea Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...RNewswire-FirstCall/ -- BioCryst Pharmaceuticals, ...of a public offering of 5,000,000 shares of its co...proceeds of $48.75 million. All of the shares are...e shelf registration statement previously filed wi...st has also granted the underwriters a 30-day opti...
(Date:11/19/2009)...re/ -- Riverain Medical announced today that the c...dical imaging distributor Christie Group to offer ...Xray CAD. The exclusive agreement will bring Dayto...anadian market through Christie Group,s establishe...nced Chest Imaging increases the clarity of digita...
(Date:11/19/2009)...RNewswire/ -- Mach 7 Technologies, a global prov...nagement solutions, and QStar Technologies have si...ral archive solution through their common US distr...al leader in providing digital image distribution ...Under the agreement, Data Distributing will be abl...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 2Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 3Mach 7 Technologies and QStar Sign Agreement to Deliver PACS-Neutral Solutions Through Mutual Channel Partner, Data Distributing 4Two University of Southern California Innovators Recognized by Technology Reviews Prestigious TR35 Listing of the Worlds Top Young Innovators for 2009 13616 1Two University of Southern California Innovators Recognized by Technology Reviews Prestigious TR35 Listing of the Worlds Top Young Innovators for 2009 13616 2Two University of Southern California Innovators Recognized by Technology Reviews Prestigious TR35 Listing of the Worlds Top Young Innovators for 2009 13616 3Two University of Southern California Innovators Recognized by Technology Reviews Prestigious TR35 Listing of the Worlds Top Young Innovators for 2009 13616 4Two University of Southern California Innovators Recognized by Technology Reviews Prestigious TR35 Listing of the Worlds Top Young Innovators for 2009 13616 5Amira Pharmaceuticals Submits IND for Second DP2 Antagonist AM461 4867 1Amira Pharmaceuticals Submits IND for Second DP2 Antagonist AM461 4867 2Video Gamers Older Than You Think 54770 1Video Gamers Older Than You Think 54770 2Video Gamers Older Than You Think 54770 3Video Gamers Older Than You Think 54770 4
...rmany, August 22 , - Dangerous Bacteria Infect Th...s something well-tried can also be innovative: alr...e very antimicrobial. This,ability is now playing ...s,hospital germs. In a worldwide noted field test,...Wandsbek in Hamburg, Germany, was equipped with,do...
...Kan., Aug. 21 Dangerous disease,often spreads fas...medy,that, researchers at Kansas State University ... down to hours., Sanjeev Narayanan, assistant pro..., both in the department of diagnostic medicine an...microarray to seek out the,specific genetic marker...
Other Medicine Technology:Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 2Copper Eliminates Resistant Hospital Germs in a Worldwide Field Test 3Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists 2
(Date:11/20/2009)...DISON, N.J., Nov. 20 Rat...ay have peaked in late October, but the pandemic f...ness in all age groups, including the elderly, acc...orated (NYSE: DGX ), the world,s leading provide... ,, In its most recent Quest Diagnostics Healt...
(Date:11/20/2009)...ON-SALEM, N.C., Nov. 20 ...sion to redefine what it means to be "happy" durin...or with a specialty in family counseling and chair...iversity, Gladding says research shows that it is ...ss and even depression during the holidays. ,, ...
(Date:11/20/2009)... of exposure to formaldehyde used for embalming in...eased risk of death from myeloid leukemia, accordi...the Journal of the National Cancer Institute . ,...m lymphohematopoietic malignancies and brain cance...y workers, all of whom may have worked with formal...
(Date:11/20/2009)...,s as short as 34 weeks, potentially adding to pre...AY, Nov. 20 (HealthDay News) -- Recent reports sho... climb in the United States. Now, a new study sug...t what constitutes a full-term birth in the first ...yed in the study considered a baby born at 34 to 3...
(Date:11/20/2009)... Longtime OB/GYN warns against the new br...reventative Services Task Force. These guidelines ...of human lives. When is it wrong to be safe than s...entative Services Task Force recommendations, publ...al Medicine, has set off a firestorm in the medica...
Breaking Medicine News(10 mins):Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3
...apy for early outset glaucoma appears to slow the ...ediate treatment of the most common form of glauco...s.// This has very few significant signs. Doctors ...of the group was treated with medicine and laser t...
...to researchersthey studied on miceand found that ... cells and eliminate them. Glioma is the most aggr...ll-defined, with malignant// cells making their wa... Institute have found that neural stem cells can t...
...cant focussed technique of radiation therapy promi...ase. These days a full cure is likely for most of ...ecovery may be impaired by short and long-term com...t researchers at Stanford University have been dev...
...iant that is linked to an increase in the risk of ...h diabetes are most likely to suffer neuropathy. I...thy in the lower limbs - that is, //peripheral ner...d a gene variant which makes people more likely to...
...to a Norwegian study of 1656 subjects over an elev...mes in the workplace is linked to a significant in...subjects from the city of Bergen and its surroundi...f the original participants were revisited. The su...
...to this new study it shows that women are more sen... in the US investigated a group of 60 women and 30...ugh.// They had them inhale substances that cause ...substances used were capsaicin, the hot substance ...
Other Medicine News:
...rs a complete line of flowmeters, available in oxy... in a variety of calibrations to best suit your ap...fic to the gas in use, the Amvex Flowmeter is a us...U with I. For Power Take-Off add PT to the end of ...
...rs a complete line of flowmeters, available in oxy... in a variety of calibrations to best suit your ap...fic to the gas in use, the Amvex Flowmeter is a us...U with I. For Power Take-Off add PT to the end of ...
MRI Compatible Slim Line Flowmeter
0-3.5 LPM Oxygen Flowmeter - 1/8" NPT Female Inlet
Medicine Products: